SAFE Tax Filing Act of 2025

Senate Bill

S. 2129

119th Congress

SAFE Tax Filing Act of 2025

In Committee

Introduced:Jun 18, 2025

Primary Sponsor

James Lankford

R - OK

Cosponsors

5

Quick Stats

Policy Area

Health

Summary

The SAFE Tax Filing Act of 2025 requires Medicare prescription drug plans to include more generic and biosimilar drugs on their formularies. This means seniors enrolled in Medicare would have better access to lower-cost alternative medicines.

Latest Action

Read twice and referred to the Committee on Finance.

Introduced6/18/2025

StatusRead twice and referred to the Committee on Finance.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

SAFE Tax Filing Act of 2025

The SAFE Tax Filing Act of 2025 requires Medicare prescription drug plans to include more generic and biosimilar drugs on their formularies. This means seniors enrolled in Medicare would have better access to lower-cost alternative medicines.

Community Breakdown

Pass

0%

Fail

0%

0 predictions

The SAFE Tax Filing Act of 2025 requires Medicare prescription drug plans to include more generic and biosimilar drugs on their formularies. This means seniors enrolled in Medicare would have better access to lower-cost alternative medicines.

Bill Number: 2129
Introduced: 6/18/2025
Status: Read twice and referred to the Committee on Finance.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: SAFE Tax Filing Act of 2025
Bill Number: 2129
Sponsor: No sponsor
Status: Read twice and referred to the Committee on Finance.
Introduced: 6/18/2025
Summary: The SAFE Tax Filing Act of 2025 requires Medicare prescription drug plans to include more generic and biosimilar drugs on their formularies. This means seniors enrolled in Medicare would have better access to lower-cost alternative medicines.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

The SAFE Tax Filing Act of 2025 requires Medicare prescription drug plans to include more generic and biosimilar drugs on their formularies. This means seniors enrolled in Medicare would have better access to lower-cost alternative medicines.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Ensuring Access to Lower-Cost Medicines for Seniors ActThis bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.

Key Points

Main provisions of the bill

Requires Medicare drug plans to include generic drugs and biosimilars on their formularies
Plans cannot have more restrictive requirements for generic/biosimilar drugs compared to brand-name drugs
Requires specific cost-sharing tiers for generic drugs and biosimilars

How This Impacts Americans

Potential effects on citizens and communities

This bill would directly benefit Medicare beneficiaries by improving their access to more affordable prescription drug options. Seniors often live on fixed incomes, so having access to lower-cost generic and biosimilar alternatives could save them significant out-of-pocket costs. The increased competition from generics and biosimilars could also help lower drug prices overall.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2129, 119th Congress (2025). "SAFE Tax Filing Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-s-2129

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.